Your browser doesn't support javascript.
loading
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.
Laprie, Anne; Ken, Soléakhéna; Filleron, Thomas; Lubrano, Vincent; Vieillevigne, Laure; Tensaouti, Fatima; Catalaa, Isabelle; Boetto, Sergio; Khalifa, Jonathan; Attal, Justine; Peyraga, Guillaume; Gomez-Roca, Carlos; Uro-Coste, Emmanuelle; Noel, Georges; Truc, Gilles; Sunyach, Marie-Pierre; Magné, Nicolas; Charissoux, Marie; Supiot, Stéphane; Bernier, Valérie; Mounier, Muriel; Poublanc, Muriel; Fabre, Amandine; Delord, Jean-Pierre; Cohen-Jonathan Moyal, Elizabeth.
Afiliación
  • Laprie A; Radiation Oncology Department, Institut Claudius Regaud- Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France. laprie.anne@iuct-oncopole.fr.
  • Ken S; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, INSERM, UPS, Toulouse, France. laprie.anne@iuct-oncopole.fr.
  • Filleron T; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, INSERM, UPS, Toulouse, France.
  • Lubrano V; Department of Engineering and Medical Physics, Institut Claudius Regaud- Institut Universitaire du Cancer de Toulouse-OncopoleCancer de Toulouse-Oncopole, Toulouse, France.
  • Vieillevigne L; Biostatistics Unit, Institut Claudius Regaud- Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Tensaouti F; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, INSERM, UPS, Toulouse, France.
  • Catalaa I; Neurosurgery Department, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Boetto S; Department of Engineering and Medical Physics, Institut Claudius Regaud- Institut Universitaire du Cancer de Toulouse-OncopoleCancer de Toulouse-Oncopole, Toulouse, France.
  • Khalifa J; Radiation Oncology Department, Institut Claudius Regaud- Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Attal J; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, INSERM, UPS, Toulouse, France.
  • Peyraga G; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, INSERM, UPS, Toulouse, France.
  • Gomez-Roca C; Neuroimaging Department, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Uro-Coste E; Neurosurgery Department, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Noel G; Radiation Oncology Department, Institut Claudius Regaud- Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Truc G; Radiation Oncology Department, Institut Claudius Regaud- Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Sunyach MP; Radiation Oncology Department, Institut Claudius Regaud- Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Magné N; Medical Oncology Department, Institut Claudius Regaud- Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Charissoux M; Pathology department, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Supiot S; Radiation Oncology Department, Centre Paul Strauss, Strasbourg, France.
  • Bernier V; Radiation Oncology Department Centre Georges-François Leclerc, Dijon, France.
  • Mounier M; Radiation Oncology Department- Centre Léon Bérard, Lyon, France.
  • Poublanc M; Radiation Oncology Department, Institut de Cancérologie de la Loire, Saint-Priest en Jarez, France.
  • Fabre A; Radiation Oncology Department - Centre Val d'aurelle, Montpellier, France.
  • Delord JP; Radiation Oncology Department, Institut de Cancerologie de l'Ouest, Nantes st Herblain, France.
  • Cohen-Jonathan Moyal E; Radiation Oncology Department, Institut de cancérologie de Lorraine centre Alexis Vautrin, Nancy, France.
BMC Cancer ; 19(1): 167, 2019 Feb 21.
Article en En | MEDLINE | ID: mdl-30791889
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma / Antineoplásicos Alquilantes / Radioterapia de Intensidad Modulada / Quimioradioterapia / Temozolomida Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma / Antineoplásicos Alquilantes / Radioterapia de Intensidad Modulada / Quimioradioterapia / Temozolomida Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido